Abstract |
CD8(+) T cells recognizing minor histocompatibility antigens ( MiHA) on solid tumor cells may mediate effective graft-versus- tumor (GVT) reactivity after allogeneic stem cell transplantation (SCT). Previously, we identified LRH-1 as a hematopoietic-restricted MiHA encoded by the P2X5 gene. Here, we report that LRH-1 is aberrantly expressed on solid tumor cells. P2X5 mRNA expression is demonstrated in a significant portion of solid tumor cell lines, including renal cell carcinoma (RCC), melanoma, colorectal carcinoma, brain cancer and breast cancer. Importantly, P2X5 gene expression was also detected in a subset of primary solid tumor specimens derived from RCC, brain cancer and breast cancer patients. Furthermore, P2X5 expressing solid tumor cells can be effectively targeted by LRH-1-specific cytotoxic T lymphocytes under inflammatory conditions. The expression of HLA-B7 and CD54 on tumor cells increases upon cytokine stimulation resulting in improved T cell activation as observed by higher levels of degranulation and enhanced tumor cell lysis. Overall, hematopoietic-restricted MiHA LRH-1 is aberrantly expressed on solid tumor cells and may be used as target in GVT-specific immunotherapy after SCT.
|
Authors | Ingrid M Overes, T Henriëtte Levenga, Johanna C M Vos, Agnes van Horssen-Zoetbrood, Robbert van der Voort, Pieter H De Mulder, Theo M de Witte, Harry Dolstra |
Journal | Cancer immunology, immunotherapy : CII
(Cancer Immunol Immunother)
Vol. 58
Issue 3
Pg. 429-39
(Mar 2009)
ISSN: 1432-0851 [Electronic] Germany |
PMID | 18719914
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- DNA-Binding Proteins
- Minor Histocompatibility Antigens
- P2RX5 protein, human
- RNA, Messenger
- Receptors, Purinergic P2
- Receptors, Purinergic P2X5
- Transcription Factors
- Intercellular Adhesion Molecule-1
|
Topics |
- CD8-Positive T-Lymphocytes
(immunology)
- DNA-Binding Proteins
(metabolism, physiology)
- Genotype
- Hematopoietic System
(metabolism)
- Humans
- Immunotherapy
(methods)
- Intercellular Adhesion Molecule-1
(biosynthesis)
- Microscopy, Fluorescence
(methods)
- Minor Histocompatibility Antigens
(metabolism)
- Neoplasms
(immunology, metabolism)
- RNA, Messenger
(metabolism)
- Receptors, Purinergic P2
(metabolism)
- Receptors, Purinergic P2X5
- Stem Cell Transplantation
- T-Lymphocytes
(metabolism)
- Transcription Factors
(metabolism, physiology)
- Transplantation, Homologous
|